Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy

Objectives To develop a quality of life (QOL) survey for Krabbe disease (KD), and to thereby improve understanding of its phenotypic expression and response to treatment. Methods The survey, the Leukodystrophy Quality of Life Assessment (LQLA) and the Vineland Adaptive Behavior Scales were co‐admini...

Full description

Saved in:
Bibliographic Details
Published inJIMD reports Vol. 47; no. 1; pp. 47 - 54
Main Authors Langan, Thomas J., Barczykowski, Amy, Jalal, Kabir, Sherwood, Laura, Allewelt, Heather, Kurtzberg, Joanne, Carter, Randy L.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.05.2019
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To develop a quality of life (QOL) survey for Krabbe disease (KD), and to thereby improve understanding of its phenotypic expression and response to treatment. Methods The survey, the Leukodystrophy Quality of Life Assessment (LQLA) and the Vineland Adaptive Behavior Scales were co‐administered to 33 patients or their caretakers. These included the phenotypes of early infantile KD (EIKD; 0‐6 months old at onset), late infantile cases (LIKD; 7‐12 months old at onset), and cases that emerged after 12 months old, late onset (LOKD). The sample included cases with and without stem cell transplantation (SCT). Reliability and concurrent validity were assessed for overall and subscale scores. Analysis of variance tested differences in QOL between phenotypes and transplant groups (none, pre‐, post‐symptom). Results Good concurrent validity with the Vineland was shown for total, communication, daily activity, social, and motor scales and good reliability was observed. LOKD cases had better communication skills than either EIKD or LIKD and better overall QOL than EIKD. Analyses of individual items showed that communication items, mostly, contributed significantly to phenotype differences. Presymptomatic SCT significantly improved QOL compared to postsymptomatic SCT or no treatment. Presymptomatically treated patients had near‐normal total scores. Conclusions The LQLA is valid and reliable. Despite small sample size, phenotypic demarcation was determined to be due mainly to differences in communication skills. There was a relative enhancement of QOL in LOKD patients, and in those who had presymptomatic SCT. These results apply to the current controversy about recommendations for newborn screening for this condition.
Bibliography:Funding information
Lysosomal Disease Network, Grant/Award Number: LDN‐U54NS065768; National Institutes of Health, Grant/Award Number: R‐21 HD087818‐01
Verena Peters
Communicating Editor
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Communicating Editor: Verena Peters
Funding information Lysosomal Disease Network, Grant/Award Number: LDN‐U54NS065768; National Institutes of Health, Grant/Award Number: R‐21 HD087818‐01
ISSN:2192-8312
2192-8304
2192-8312
DOI:10.1002/jmd2.12033